BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 29790738)

  • 1. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
    Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
    Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifunctional magnetopolymersomes of iron oxide nanoparticles and carboxymethylcellulose conjugated with doxorubicin for hyperthermo-chemotherapy of brain cancer cells.
    Carvalho SM; Leonel AG; Mansur AAP; Carvalho IC; Krambrock K; Mansur HS
    Biomater Sci; 2019 Apr; 7(5):2102-2122. PubMed ID: 30869664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foot-and-mouth disease virus-like particles as integrin-based drug delivery system achieve targeting anti-tumor efficacy.
    Yan D; Teng Z; Sun S; Jiang S; Dong H; Gao Y; Wei Y; Qin W; Liu X; Yin H; Guo H
    Nanomedicine; 2017 Apr; 13(3):1061-1070. PubMed ID: 27993721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.
    Guo Y; Xu H; Li Y; Wu F; Li Y; Bao Y; Yan X; Huang Z; Xu P
    J Biomater Appl; 2017 Jul; 32(1):54-65. PubMed ID: 28554233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells.
    Cai LL; Liu P; Li X; Huang X; Ye YQ; Chen FY; Yuan H; Hu FQ; Du YZ
    Int J Nanomedicine; 2011; 6():3499-508. PubMed ID: 22282676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway.
    Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB
    Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxymethylcellulose biofunctionalized ternary quantum dots for subcellular-targeted brain cancer nanotheranostics.
    Mansur AAP; Paiva MRB; Cotta OAL; Silva LM; Carvalho IC; Capanema NSV; Carvalho SM; Costa ÉA; Martin NR; Ecco R; Santos BS; Fialho SL; Lobato ZIP; Mansur HS
    Int J Biol Macromol; 2022 Jun; 210():530-544. PubMed ID: 35513094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
    Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
    Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioengineered carboxymethyl cellulose-doxorubicin prodrug hydrogels for topical chemotherapy of melanoma skin cancer.
    Capanema NSV; Mansur AAP; Carvalho SM; Carvalho IC; Chagas P; de Oliveira LCA; Mansur HS
    Carbohydr Polym; 2018 Sep; 195():401-412. PubMed ID: 29804993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-functional supramolecular nanohybrids of quantum dot/biopolymer/chemotherapeutic drug for bioimaging and killing brain cancer cells in vitro.
    Mansur AAP; Caires AJ; Carvalho SM; Capanema NSV; Carvalho IC; Mansur HS
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110507. PubMed ID: 31542643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexation of cell-penetrating peptide-polymer conjugates with polyanions controls cells uptake of HPMA copolymers and anti-tumor activity.
    Shamay Y; Shpirt L; Ashkenasy G; David A
    Pharm Res; 2014 Mar; 31(3):768-79. PubMed ID: 24019024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy.
    Takara K; Hatakeyama H; Kibria G; Ohga N; Hida K; Harashima H
    J Control Release; 2012 Aug; 162(1):225-32. PubMed ID: 22728515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Cell-Penetrating Peptide (KRP) with Multiple Physicochemical Properties Endows Doxorubicin with Tumor Targeting and Improves Its Therapeutic Index.
    Yu M; Li X; Huang X; Zhang J; Zhang Y; Wang H
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):2448-2458. PubMed ID: 30576099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured Amphiphilic Star-Hyperbranched Block Copolymers for Drug Delivery.
    Seleci M; Seleci DA; Ciftci M; Demirkol DO; Stahl F; Timur S; Scheper T; Yagci Y
    Langmuir; 2015 Apr; 31(15):4542-51. PubMed ID: 25816726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.